Government Strategies Lack Time and Funding to Deliver Strong Results: Critics

British Columbia’s efforts to curb the toxic drug crisis continue to fall short, with critics pointing to a persistent lack of long-term funding and strategic consistency as key barriers to meaningful progress. Despite repeated policy announcements and emergency interventions, public health experts and frontline workers say the province’s approach remains reactive rather than proactive, leaving communities vulnerable to escalating overdose deaths and related harms.

Persistent Gaps in BC’s Toxic Drug Response

The province’s struggle to contain the toxic drug supply has been a recurring theme in public health discussions, particularly as fentanyl and other synthetic opioids dominate the unregulated market. While BC declared a public health emergency in 2016—making it the first jurisdiction in Canada to do so—the crisis has only deepened in the years since. Data from the BC Coroners Service shows that illicit drug toxicity remains the leading cause of unnatural death in the province, with more than 2,500 lives lost in 2025 alone. The figures represent a slight decline from the peak of 2023, but experts caution that the reduction is marginal and may not reflect sustained systemic improvements.

Critics argue that the government’s reliance on short-term funding cycles and piecemeal interventions has undermined the potential of evidence-based strategies. Dr. Jane Buxton, a harm reduction epidemiologist with the BC Centre for Disease Control, has previously emphasized that effective public health responses require “consistent, multi-year investments” to build trust, infrastructure, and community capacity. Yet, many programs—such as supervised consumption sites, drug-checking services, and prescribed safer supply initiatives—operate under temporary funding models, creating instability for both providers and participants.

Funding Instability and Policy Reversals

One of the most contentious issues is the province’s handling of safer supply programs, which provide pharmaceutical alternatives to the toxic street drug supply. While BC expanded these initiatives in 2021 as part of its broader harm reduction strategy, recent policy shifts have introduced new restrictions, including stricter eligibility criteria and dosage limits. Advocates say the changes reflect a lack of political will to scale up proven interventions, instead opting for incremental adjustments that fail to address the root causes of the crisis.

A 2025 report from the BC Centre on Substance Use (BCCSU) found that safer supply programs were associated with a 61% reduction in overdose-related hospitalizations among participants. However, the report also noted that coverage remained uneven, with rural and Indigenous communities facing significant barriers to access. The BCCSU recommended expanding the program to include a broader range of medications and removing bureaucratic hurdles, but provincial officials have not yet committed to these changes.

Funding instability extends beyond safer supply. Supervised consumption sites, which provide a controlled environment for people to use drugs under medical supervision, have faced repeated threats of closure due to inconsistent provincial support. In 2024, the BC government announced a review of all such sites, citing concerns about “community impact” and “public safety.” While the review ultimately reaffirmed the sites’ value, the process created uncertainty for operators and service users, many of whom rely on these spaces for life-saving interventions.

Systemic Barriers to Long-Term Solutions

Public health researchers highlight several structural challenges that hinder BC’s ability to implement durable solutions. One major issue is the fragmentation of services across different levels of government. While the provincial Ministry of Mental Health and Addictions leads policy development, implementation often falls to regional health authorities, non-profits, and municipal governments, each with varying capacities and priorities. This decentralized approach can lead to inconsistent service delivery and gaps in coverage, particularly in remote and underserved areas.

Another barrier is the persistent stigma surrounding substance use, which influences both policy decisions and public perception. A 2025 survey conducted by the Canadian Centre on Substance Use and Addiction found that 42% of British Columbians still believe addiction is a “moral failing” rather than a health issue. This stigma can deter people from seeking help and undermine political support for harm reduction initiatives. Experts say addressing these attitudes requires sustained public education campaigns, but such efforts have been underfunded relative to the scale of the crisis.

The criminalization of drug possession also remains a contentious issue. While BC decriminalized small amounts of certain drugs in 2023—a move intended to reduce barriers to treatment and harm reduction services—the policy has faced criticism for its limited scope. The threshold for decriminalization (2.5 grams) is widely considered too low to meaningfully reduce arrests, and police discretion in enforcement has led to uneven application. Advocates argue that full decriminalization, coupled with expanded access to treatment and housing, is necessary to shift the focus from punishment to public health.

What Comes Next?

As BC approaches the eighth year of its public health emergency, the province’s next steps remain uncertain. The Ministry of Mental Health and Addictions has signaled plans to introduce a new “comprehensive” strategy in mid-2026, but details have not been released. In the meantime, frontline workers and public health experts continue to call for urgent action on several fronts:

• Expanding safer supply programs to include a wider range of medications and removing eligibility restrictions.
• Increasing funding for supervised consumption sites, particularly in rural and Indigenous communities.
• Implementing a province-wide drug-checking network to provide real-time information about the toxic drug supply.
• Strengthening mental health and addiction treatment services, including culturally safe care for Indigenous peoples.
• Launching a long-term public education campaign to combat stigma and promote harm reduction.

For now, the crisis shows no signs of abating. Overdose deaths continue to outpace those from car accidents, homicides, and suicides combined, and the toxic drug supply remains as unpredictable as ever. Without sustained investment and political commitment, critics warn that BC’s efforts will continue to flounder, leaving vulnerable communities to bear the brunt of the crisis.

The situation in BC reflects broader challenges in Canada’s approach to substance use and addiction. While harm reduction strategies have gained traction in recent years, their implementation has often been uneven, with funding and policy shifts creating instability for both providers and service users. As other provinces grapple with similar crises, the lessons from BC underscore the need for long-term, evidence-based solutions that prioritize public health over short-term political considerations.